If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Olumiant192
Janus kinase 1 and 2 inhibitor
Rheumatoid arthritis
Ruxolitinib, tofacitinib
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules >Inhibitors of JAK1 and JAK2
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals